Gregory P. Forlenza

10.0k total citations · 2 hit papers
141 papers, 3.9k citations indexed

About

Gregory P. Forlenza is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Gregory P. Forlenza has authored 141 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Endocrinology, Diabetes and Metabolism, 101 papers in Surgery and 76 papers in Genetics. Recurrent topics in Gregory P. Forlenza's work include Diabetes Management and Research (129 papers), Pancreatic function and diabetes (101 papers) and Diabetes and associated disorders (75 papers). Gregory P. Forlenza is often cited by papers focused on Diabetes Management and Research (129 papers), Pancreatic function and diabetes (101 papers) and Diabetes and associated disorders (75 papers). Gregory P. Forlenza collaborates with scholars based in United States, United Kingdom and Australia. Gregory P. Forlenza's co-authors include Laurel H. Messer, Cari Berget, R. Paul Wadwa, Bruce A. Buckingham, David M. Maahs, Laura Pyle, Tim Vigers, Marc D. Breton, Laya Ekhlaspour and Mark D. DeBoer and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Diabetes Care.

In The Last Decade

Gregory P. Forlenza

128 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

2020 284 citations Marc D. Breton, Roy W. Beck et al. profile →
Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes

2023 81 citations R. Paul Wadwa, Bruce A. Buckingham et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory P. Forlenza United States	36	3.4k	2.6k	2.2k	197	151	141	3.9k
Jennifer L. Sherr United States	32	3.1k 0.9×	2.2k 0.9×	1.9k 0.9×	145 0.7×	71 0.5×	115	3.5k
Laurel H. Messer United States	32	2.4k 0.7×	1.6k 0.6×	1.5k 0.7×	203 1.0×	87 0.6×	92	2.8k
Hood Thabit United Kingdom	31	2.7k 0.8×	1.9k 0.7×	1.6k 0.7×	205 1.0×	113 0.7×	97	3.4k
Eda Cengiz United States	28	2.4k 0.7×	1.6k 0.6×	1.4k 0.6×	97 0.5×	144 1.0×	79	2.8k
Lalantha Leelarathna United Kingdom	33	2.5k 0.7×	1.7k 0.6×	1.4k 0.6×	162 0.8×	86 0.6×	91	2.8k
John Shin United States	27	2.4k 0.7×	1.9k 0.7×	1.5k 0.7×	104 0.5×	96 0.6×	98	3.2k
Craig Kollman United States	28	2.4k 0.7×	1.7k 0.7×	1.5k 0.7×	87 0.4×	80 0.5×	52	3.3k
Daniela Bruttomesso Italy	32	2.7k 0.8×	1.6k 0.6×	1.4k 0.6×	260 1.3×	143 0.9×	101	3.6k
Nataša Bratina Slovenia	29	2.0k 0.6×	1.6k 0.6×	1.4k 0.6×	110 0.6×	42 0.3×	82	2.5k
Jessica R. Castle United States	30	1.9k 0.5×	1.3k 0.5×	980 0.4×	116 0.6×	225 1.5×	85	2.4k

Countries citing papers authored by Gregory P. Forlenza

Since Specialization

Citations

This map shows the geographic impact of Gregory P. Forlenza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory P. Forlenza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory P. Forlenza more than expected).

Fields of papers citing papers by Gregory P. Forlenza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory P. Forlenza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory P. Forlenza. The network helps show where Gregory P. Forlenza may publish in the future.

Co-authorship network of co-authors of Gregory P. Forlenza

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory P. Forlenza. A scholar is included among the top collaborators of Gregory P. Forlenza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory P. Forlenza. Gregory P. Forlenza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berget, Cari, Francesca Annan, Torben Biester, et al.. (2025). Practical considerations for using the Omnipod® 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe. Diabetes Obesity and Metabolism. 27(6). 2909–2919. 1 indexed citations

Bergenstal, Richard M., Adam Heller, Marc D. Breton, et al.. (2025). Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems. Journal of Diabetes Science and Technology. 19(4). 883–894. 1 indexed citations

Messer, Laurel H., Gregory P. Forlenza, Linda Gonder‐Frederick, et al.. (2025). Practical Considerations and Implementation of Automated Insulin Delivery Systems. Journal of Diabetes Science and Technology. 19(4). 950–957. 1 indexed citations

Messer, Laurel H., Gregory P. Forlenza, Linda Gonder‐Frederick, et al.. (2025). Practical Considerations and Implementation of Automated Insulin Delivery Systems. Diabetes Technology & Therapeutics. 27(3_suppl). S72–S78. 1 indexed citations

Forlenza, Gregory P., et al.. (2025). Glucagon-like Peptide-1 Receptor Agonists (GLP-1-RA) and GLP-1/Gastrointestinal Peptide RA (GLP-1/GIP-RA) Use in Adolescents and Young Adults with Type 1 Diabetes and Overweight or Obesity. 1(1). 50–55.

Jost, Emily, Laurel H. Messer, Paul Cook, et al.. (2024). “Obviously, Nothing's Gonna Happen in Five Minutes”: How Adolescents and Young Adults Infrastructure Resources to Learn Type 1 Diabetes Management. PubMed. 2024. 1–16. 1 indexed citations

Brown, Sue A., Lori M. Laffel, Halis Kaan Aktürk, et al.. (2024). Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers with Varying Levels of Baseline Glycemic Control. Diabetes Technology & Therapeutics. 27(3). 187–193.

Hood, Korey K., William H. Polonsky, Sarah A. MacLeish, et al.. (2023). Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers. Pediatric Diabetes. 2023. 1–12. 6 indexed citations

Forlenza, Gregory P., et al.. (2023). Noninvasive Glucose Sensing In Vivo. Sensors. 23(16). 7057–7057. 10 indexed citations

10.

Alonso, G. Todd, Taylor M. Triolo, Halis Kaan Aktürk, et al.. (2023). Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population. Diabetes Care. 46(6). 1218–1222. 22 indexed citations

11.

Messer, Laurel H., Paul Cook, Stephen Voida, et al.. (2023). Situational Awareness and Proactive Engagement Predict Higher Time in Range in Adolescents and Young Adults Using Hybrid Closed-Loop. Pediatric Diabetes. 2023. 1–8. 1 indexed citations

12.

Sawyer, Alexandra, et al.. (2022). Glycemic Control in Relation to Technology Use in a Single-Center Cohort of Children with Type 1 Diabetes. Diabetes Technology & Therapeutics. 24(6). 409–415. 15 indexed citations

13.

Forlenza, Gregory P. & Rayhan Lal. (2022). Current Status and Emerging Options for Automated Insulin Delivery Systems. Diabetes Technology & Therapeutics. 24(5). 362–371. 38 indexed citations

14.

Messer, Laurel H., Bruce A. Buckingham, Fran R. Cogen, et al.. (2022). Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6–17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial. Diabetes Technology & Therapeutics. 24(10). 712–725. 29 indexed citations

15.

Messer, Laurel H., et al.. (2021). Initiating hybrid closed loop: A program evaluation of an educator‐led Control‐IQ follow‐up at a large pediatric clinic. Pediatric Diabetes. 22(4). 586–593. 11 indexed citations

16.

Forlenza, Gregory P., Tim Vigers, Cari Berget, et al.. (2021). Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study. Diabetes Technology & Therapeutics. 24(3). 157–166. 9 indexed citations

17.

Vigers, Tim, et al.. (2020). Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology. Journal of Diabetes Science and Technology. 15(3). 630–635. 19 indexed citations

18.

Sopfe, Jenna, Laura Pyle, Amy K. Keating, et al.. (2019). Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients. Blood Advances. 3(3). 350–359. 16 indexed citations

19.

Spaic, Tamara, Marsha Driscoll, Dan Raghinaru, et al.. (2017). Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes. Diabetes Care. 40(3). 359–366. 17 indexed citations

20.

Forlenza, Gregory P., Srinath Chinnakotla, Sarah Jane Schwarzenberg, et al.. (2014). Near-Euglycemia Can Be Achieved Safely in Pediatric Total Pancreatectomy Islet Autotransplant Recipients Using an Adapted Intravenous Insulin Infusion Protocol. Diabetes Technology & Therapeutics. 16(11). 706–713. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact